Coronary disease & ACSSecondary analysis

Sex differences in computed tomography-derived fractional flow reserve-guided management of stable coronary artery disease: a subgroup analysis of the TARGET trial

EuroInterventionPublished

  • post hoc subanalysis of the randomised TARGET trial

Authors' conclusion

CT-FFR-guided management was associated with different clinical patterns between females and males. Particularly in males, CT-FFR guidance reduced unnecessary angiography. A lower 2-year adverse event rate was observed among females in the CT-FFR group. However, given the absence of a statistically significant interaction between sex and treatment strategy, these findings should be considered exploratory and hypothesis-generating. (ClinicalTrials.gov: NCT03901326).

Study context

Population
Patients with stable coronary artery disease (CAD) with 30–90% coronary stenosis on coronary computed tomography angiography (CCTA)randomised
Participants
1,216 patients
Comparison
onsite CT-FFR-guided care or standard care, by sex
Primary endpoint
proportion of patients who underwent ICA without obstructive CAD or had no intervention despite obstructive CAD on ICA
Follow-up
Within 90 days of CCTA

Primary result

As reported in the abstract

  • CT-FFR-guided care significantly reduced invasive coronary angiography (ICA) without obstructive CAD and increased early revascularisation in males but not in females

Secondary outcomes

OutcomeValuesadjusted HR (95% CI)P value
MACE (secondary endpoint) · 2 years — CT-FFR-guided care vs standard care · females0.48 (0.27–0.87)P = 0.015
MACE (secondary endpoint) · 2 years — CT-FFR-guided care vs standard care · males0.89 (0.59–1.33)P = 0.574
OutcomeValuesEstimateP value
Age, females vs males · comparable anatomical CAD severityFemales mean 62.3 (SD 8.1) years · Males mean 58.2 (SD 10.7) yearsP < 0.001
  • Major adverse cardiovascular events (MACE) (secondary endpoint): no statistically significant interaction between sex and treatment strategy

Original publication

Sex differences in computed tomography-derived fractional flow reserve-guided management of stable coronary artery disease: a subgroup analysis of the TARGET trial. EuroIntervention. Published 7 September 2026. doi:10.4244/eij-d-25-01383

Summarised from the published abstract; every number is checked against it